-
Achieving Health Equality
National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.
by Marci A. Landsmann
-
The Roots of Rural Health Disparities
New research shows that rural cancer patients have the same health outcomes as urban cancer patients so long as they are involved in a clinical trial.
by Cheryl Platzman Weinstock
-
A New Guideline for Cervical Cancer Screening
Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.
by Anna Azvolinsky
-
Omitting Obesity
Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.
by Cici Zhang
-
Men Less Likely to Get Genetic Testing
A study suggests women are more likely than men to undergo genetic testing for mutations linked to hereditary cancer.
by Cheryl Platzman Weinstock
-
The Many Faces of Patient Advocacy
Advocates shared their stories and projects at the AACR Annual Meeting.
by Kate Yandell
-
A Response to Roadblocks
The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
by Kevin McLaughlin
Previous |
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles